TransMedics (TMDX) Payables (2018 - 2026)

TransMedics' Payables history runs 9 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• On a quarterly basis, Payables rose 5.25% year-over-year to $11.2 million in Q1 2026; TTM through Mar 2026 was $11.2 million, a 5.25% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 0.56% from the prior year.
• Payables grew to $11.2 million in Q1 2026 per TMDX's latest filing, from $10.4 million in the prior quarter.
• Across five years, Payables topped out at $13.1 million in Q3 2024 and bottomed at $2.9 million in Q1 2022.
• The 5-year median for Payables is $10.3 million (2024), against an average of $8.9 million.
• Across the five-year window, Payables slumped 49.77% in 2022 and jumped 316.75% in 2023, its largest moves.
• Year by year, Payables stood at $3.3 million in 2022, then soared by 280.63% to $12.7 million in 2023, then retreated by 19.07% to $10.3 million in 2024, then grew by 0.56% to $10.4 million in 2025, then rose by 7.74% to $11.2 million in 2026.
• Per Business Quant, the three latest TMDX Payables figures stand at $11.2 million (Q1 2026), $10.4 million (Q4 2025), and $12.2 million (Q3 2025).